Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2024: USD 277.59 K

Fusion Antibodies plc Depreciation And Amortization is USD 277.59 K for the year ending March 31, 2024. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2022 was USD 986.34 K, a 0.27% change year over year.
  • Fusion Antibodies plc Depreciation And Amortization for the year ending March 31, 2021 was USD 983.70 K.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased